These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2590542)

  • 1. Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative Group.
    Neijt JP; van der Burg ME; Guastalla JP; George M; Piccart M; Vermorken J; Carnino F; Rotmensz N
    Acta Oncol; 1989; 28(5):663-5. PubMed ID: 2590542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of mitozolomide in ovarian cancer.
    Harding M; Northcott D; Smyth J; Stuart NS; Green JA; Newlands E
    Br J Cancer; 1988 Jan; 57(1):113-4. PubMed ID: 3348943
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    van Oosterom AT; Stoter G; Bono AV; Splinter TA; Fossa SD; Verbaeys AJ; de Mulder PH; de Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1249-50. PubMed ID: 2767112
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of mitozolomide (M & B 39,565) in colorectal and breast cancer.
    Herait P; Rougier P; Oliveira J; Delgado FM; May-Levin F; Hayat M; Armand JP
    Invest New Drugs; 1988 Dec; 6(4):323-5. PubMed ID: 3229944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group Study.
    George M; Scotto V; Carnino F; Dodion P; ten Bokkel Huinink WW; Rotmensz N; Vermorken JB
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):867-9. PubMed ID: 3653204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II studies of mitozolomide in melanoma, lung and ovarian cancer.
    Harding M; Docherty V; Mackie R; Dorward A; Kaye S
    Eur J Cancer Clin Oncol; 1989 May; 25(5):785-8. PubMed ID: 2544429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease.
    Gundersen S; Aamdal S; Fodstad O
    Br J Cancer; 1987 Apr; 55(4):433-5. PubMed ID: 3580266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.
    Somers R; Santoro A; Verweij J; Lucas P; Rouëssé J; Kok T; Casali A; Seynaeve C; Thomas D
    Eur J Cancer; 1992; 28A(4-5):855-7. PubMed ID: 1524907
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group.
    Smyth JF; Gundersen S; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):755-7. PubMed ID: 2714350
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of mitozolomide (M & B 39,565) in head and neck cancer.
    Herait P; Armand JP; Benahmed M; Domenge C; Fontana X; Recondo G; Cvitkovic E; Delgado FM
    Med Oncol Tumor Pharmacother; 1989; 6(4):267-9. PubMed ID: 2615530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical trial of mitozolomide.
    Newlands ES; Blackledge G; Slack JA; Goddard C; Brindley CJ; Holden L; Stevens MF
    Cancer Treat Rep; 1985; 69(7-8):801-5. PubMed ID: 4016790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abbreviated phase I clinical trial of i.v. mitozolomide.
    Joss RA; Ryssel HJ; Bischoff AK; Goldhirsch A; Brunner KW
    Cancer Treat Rep; 1986 Jun; 70(6):797-8. PubMed ID: 3524827
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder.
    Blackledge G; Roberts JT; Kaye S; Taylor R; Williams J; de Stavola B; Uscinska B
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):391-2. PubMed ID: 2702992
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I study of mitozolomide on a once daily for 5 days schedule.
    Schornagel JH; Simonetti G; Dubbelman R; ten Bokkel Huinink WW; McVie JG
    Cancer Chemother Pharmacol; 1990; 26(3):237-8. PubMed ID: 2357772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1st experiences in the treatment of ovarian tumors with Peptichemio].
    Natale N; Mangioni C; Remotti G
    Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between the pharmacokinetics and toxicity of mitozolomide.
    Kerr DJ; Slack JA; Secrett P; Stevens MF; Blackledge GR; Bradley C; Kaye SB
    Cancer Chemother Pharmacol; 1990; 25(5):352-4. PubMed ID: 2306796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of phenesterin in patients with advanced ovarian cancer.
    Bloom RE; Polivogianis L; Davis TE; Bennett JM; Horton J
    Cancer Treat Rep; 1983 Jun; 67(6):601-2. PubMed ID: 6861167
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
    Kato T; Nishimura H; Yakushiji M; Noda K; Terashima Y; Takeuchi S; Takamizawa H; Suzuki M; Arai M; Ota M
    Gan To Kagaku Ryoho; 1992 May; 19(5):695-701. PubMed ID: 1580643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
    Long HJ; Laurie JA; Wieand HS; Edmonson JH; Levitt R; Krook JE; Abu-Ghazaleh S
    Cancer; 1991 Aug; 68(4):730-2. PubMed ID: 1830238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
    Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.